# Unicohealth

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/unicohealth

- Industry: Biotechnology
- Headquarters: Guangzhou, China
- Website: www.unicohealth.com
- Latest round: Angel (Jun 29, 2017)
- Investors on record: 3

## About

Established in 2016 and based in Guangzhou, China, Unicohealth operates as a diagnostic reagent development platform that provides diagnostic reagent and biologics. It has obtained more than 10 domestic and foreign invention patents. The company has also cooperated with Sun Yat-sen University, Guangdong South China New Drug Creation Center, Guangzhou Institute of Microbiology and other scientific research institutions.

The company's products cover many fields, including clinical rapid diagnostic reagents, immunodiagnostic reagents, clinical haematology and body fluid test reagents, microbiology test reagents, molecular biology test reagents, clinical biochemical reagents, organic reagents, etc. The company's innovative recombinant protein drugs can be used to treat infertility, cardiovascular and cerebrovascular diseases, critical illnesses, cancer and other diseases.

The company generates revenue by developing innovative recombinant protein drugs for the treatment of infertility, cardiovascular and cerebrovascular diseases, critical illnesses, cancer and other diseases.

## Funding rounds

- Angel, Jun 29, 2017 — Guangzhou Financial Innovation Investment Holdings, Guangzhou Guoju Venture Capital, Hangzhou Ruomu Zhizang Investment Management

## Investors

- Guangzhou Financial Innovation Investment Holdings (https://capitalatlas.ai/funds/guangzhou-financial-innovation-investment-holdings) — Angel
- Guangzhou Guoju Venture Capital (https://capitalatlas.ai/funds/guangzhou-guoju-venture-capital) — Angel
- Hangzhou Ruomu Zhizang Investment Management — Angel